Skip to main content

cancer biology Archives

Colon cancer’s cellular crossroads

Mar. 16, 2012—New information about signaling pathways involved in colorectal cancer could aid in assessing prognosis and identifying new therapeutic targets for the disease.

Read more


Investigators seek clues to resistance to melanoma drug

Jan. 26, 2012—Investigators at Vanderbilt-Ingram Cancer Center and several other centers may be one step closer to finding out why some melanoma patients relapse after treatment with a promising new drug.

Read more


Protein repairs esophageal DNA damage

Jan. 25, 2012—A protein involved in repairing DNA damage associated with gastric reflux may play a tumor suppressor role in the esophagus and could represent a target for therapies to combat esophageal cancer.

Read more


Virus-linked cancer gets help from host

Dec. 15, 2011—Host cell protein may be a target for strategies to limit spread of virus-induced squamous cell cancers.

Read more


Pathway to colon cancer progression

Dec. 1, 2011—Molecular players involved in colon cancer progression could provide new biomarkers to indicate invasiveness and prognosis.

Read more


Protecting brainpower during radiation

Jun. 29, 2011—Blocking a certain protein during radiation to treat brain cancers could protect the brain’s thinking powers.

Read more


Protein related to aging holds breast cancer clues

Feb. 1, 2011—The most common type of breast cancer in older women – estrogen and progesterone receptor (ER/PR) positive breast cancer – has been linked to a protein that fends off aging-related cellular damage. A new study led by Vanderbilt-Ingram Cancer Center researcher David Gius now shows how a deficiency in this aging-associated protein may set the...

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more